Clinical Trials Logo

Clinical Trial Summary

The purpose of this research study is to learn about the safety and feasibility of giving a personalized DNA vaccine to people with brain tumors that have returned or have been resistant to treatment.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03988283
Study type Interventional
Source Washington University School of Medicine
Contact Margaret S Shatara, M.D.
Phone 314-454-6018
Email shatara@wustl.edu
Status Not yet recruiting
Phase Phase 1
Start date June 30, 2024
Completion date December 31, 2030